LIDDS
0,052
SEK
+36,84 %
Mindre end 1K følgere
LIDDS
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+36,84%
-56,3%
-58,57%
-48,77%
-48%
-68,48%
-99,07%
-99,66%
-99,46%
LIDDS is a pharmaceutical company. The company develops pharmaceutical products based on a patent-protected and clinically tested drug delivery technology. The properties of the products form the basis of LIDDS 'technology platform for the development of injectable drug products. LIDDS is the abbreviation for Local Intelligent Drug Delivery System and the company is headquartered in Uppsala.
Læs mereMarkedsværdi
7,1 mio. SEK
Aktieomsætning
4,06 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
29.5
2025
Delårsrapport Q1'25
29.5
2025
Generalforsamling '25
28.8
2025
Delårsrapport Q2'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
LIDDS has decided to cease further development
LIDDS AB (publ) Year-end Report 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools